Skip to main content
. 2021 Nov 9;12(5):2550–2567. doi: 10.1016/j.apsb.2021.11.004

Figure 5.

Figure 5

In vivo antitumor efficiency of combination therapy. (A) Schematic illustration of the anti-primary tumor experiment. 4T1 tumor growth inhibition curve (B), tumor weight and inhibition ratio (C) and images of excised tumors (D) after treated with different groups (n = 8). (E) Survival rate of 4T1 tumor-bearing mice in various groups (n = 12). Statistical P values: ∗∗P < 0.01, ∗∗∗P < 0.001.